What does the report of the USMHRP Phase III study in Thailand mean for HIV and for vaccine developers?
Graham
Barney S
BS
Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA.
D016915:AIDS Vaccines; D017326:Clinical Trials, Phase III as Topic; D015658:HIV Infections / Q000276:immunology / Q000517:prevention & control* / Q000635:transmission; D015497:HIV-1; D006801:Humans
D016915:AIDS Vaccines